Fat-soluble Vitamin Deficiencies and Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.

Fat-soluble Vitamin Deficiencies and Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2017 Aug 30;: Authors: Fabisiak N, Fabisiak A, Watala C, Fichna J Abstract BACKGROUND: Vitamin deficiency is frequently associated with inflammatory bowel disease (IBD). Supplementation of vitamins could thus serve as an adjunctive therapy. The present meta-analysis reviews the deficiencies and alterations in serum fat-soluble vitamins (A, D, E, and K) reported in IBD patients. MATERIALS AND METHODS: PubMed database search was performed to identify all primary studies up to January 2015 that evaluated the serum…

Read More

Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease.

Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 Jul 11;: Authors: Syed S, Michalski ES, Tangpricha V, Chesdachai S, Kumar A, Prince J, Ziegler TR, Suchdev PS, Kugathasan S Abstract BACKGROUND: Anemia, iron deficiency, and hypovitaminosis D are well-known comorbidities in inflammatory bowel disease (IBD). Epidemiologic studies have linked vitamin D deficiency with increased risk of anemia, and in vitro studies suggest that vitamin D may improve iron recycling through downregulatory effects on hepcidin and proinflammatory cytokines. METHODS:…

Read More

Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population.

Related Articles Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population. Dig Dis Sci. 2017 May 25;: Authors: Zullow S, Jambaulikar G, Rustgi A, Quezada S, Cross RK Abstract INTRODUCTION: Many patients with inflammatory bowel disease (IBD) are vitamin D deficient. The purpose of our study was to identify risk factors for vitamin D deficiency in IBD and to assess the impact of vitamin D repletion on disease activity and quality of life (QOL). METHODS: Patients with at least one 25-OH…

Read More

Impact of vitamin D on the hospitalization rate of Crohn’s disease patients seen at a tertiary care center.

Related Articles Impact of vitamin D on the hospitalization rate of Crohn’s disease patients seen at a tertiary care center. World J Gastroenterol. 2017 Apr 14;23(14):2539-2544 Authors: Venkata KVR, Arora SS, Xie FL, Malik TA Abstract AIM: To study the association between vitamin D level and hospitalization rate in Crohn’s disease (CD) patients. METHODS: We designed a retrospective cohort study using adult patients (> 19 years) with CD followed for at least one year at our inflammatory bowel disease center. Vitamin D levels were divided into: low mean vitamin D…

Read More

Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective.

Related Articles Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective. World J Gastroenterol. 2017 Jan 28;23(4):638-645 Authors: Pallav K, Riche D, May WL, Sanchez P, Gupta NK Abstract AIM: To identify the predictors of vitamin D deficiency in patients with and without inflammatory bowel disease (IBD). METHODS: Patients with ulcerative colitis (UC) or Crohn’s disease (CD) related diagnostic codes who received medical care at University of Mississippi Medical Center between July 2012 and 2015 were identified. After thorough chart review, we identified patients with…

Read More

Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn’s Disease in Remission: A Pilot Randomized Double-Blind Controlled Study.

Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn’s Disease in Remission: A Pilot Randomized Double-Blind Controlled Study. Dig Dis Sci. 2016 Dec 14; Authors: Narula N, Cooray M, Anglin R, Muqtadir Z, Narula A, Marshall JK Abstract AIM: To assess the tolerability and efficacy of high-dose vitamin D3 in patients with Crohn’s disease (CD). METHODS: This was a randomized, double-blind placebo-controlled trial of high-dose vitamin D3 at 10,000 IU daily (n = 18) compared to 1000 IU daily (n = 16) for 12 months in patients with CD in remission. The primary outcome was change…

Read More

Lower Vitamin D Status May Explain why African Americans Have Poorer Outcomes than Non-African Americans After Surgery for Crohn’s Disease.

Related Articles Lower Vitamin D Status May Explain why African Americans Have Poorer Outcomes than Non-African Americans After Surgery for Crohn’s Disease. J Crohns Colitis. 2016 Oct 20;: Authors: Grant WB PMID: 27797920 [PubMed – as supplied by publisher] PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/27797920?dopt=Abstract

Read More
<< Go Back